LOGICBIO THERAPEUTICS INC - COM (LOGC)

CUSIP: 54142F102

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
12,720,713
Share change
-3,280,194
Total reported value
$8,656,783
Price per share
$0.68
Number of holders
34
Value change
-$6,440,634
Number of buys
7
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 54142F102?
CUSIP 54142F102 identifies LOGC - LOGICBIO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOGICBIO THERAPEUTICS INC - COM (LOGC) as of Q1 2022

As of 31 Mar 2022, LOGICBIO THERAPEUTICS INC - COM (LOGC) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,720,713 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, FMR LLC, HARBOR CAPITAL ADVISORS, INC., BlackRock Inc., and Sio Capital Management, LLC. This page lists 34 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.